Your session is about to expire
← Back to Search
PEF Feedback for Asthma (CAPS Trial)
N/A
Waitlist Available
Led By Jonathan Feldman, PhD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-intervention to 12-month-follow-up (15 months)
Awards & highlights
CAPS Trial Summary
This trial will test whether giving feedback to adolescents with asthma about their peak expiratory flow (PEF) can help them better manage their asthma and improve their health outcomes.
Eligible Conditions
- Asthma
- Childhood Asthma
CAPS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from pre-intervention to 12-month-follow-up (15 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-intervention to 12-month-follow-up (15 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Asthma Symptom Perception with Asthma Monitor (AM2) as percentage of guesses in the Under-Perception zone
Secondary outcome measures
Asthma Control Test (C-ACT)
Asthma Illness Representation Scale (AIRS)
Asthma Management Self-Efficacy (ASE) scale: Parent and child versions
+3 moreCAPS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PEF FeedbackExperimental Treatment1 Intervention
This group will have 9 visits across 15 months.
Group II: Control FeedbackActive Control1 Intervention
This group will have 9 visits across 15 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PEF Feedback
2019
N/A
~430
Find a Location
Who is running the clinical trial?
Albert Einstein College of MedicineLead Sponsor
287 Previous Clinical Trials
11,856,745 Total Patients Enrolled
4 Trials studying Asthma
703 Patients Enrolled for Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,836 Previous Clinical Trials
47,850,494 Total Patients Enrolled
276 Trials studying Asthma
112,188 Patients Enrolled for Asthma
Jonathan Feldman, PhDPrincipal InvestigatorAlbert Einstein College of Medicine
1 Previous Clinical Trials
53 Total Patients Enrolled
1 Trials studying Asthma
53 Patients Enrolled for Asthma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger